i beg to differ.
Some here, and elsewhere, perhaps, jump on the wagon because they have faith in the story and nothing to do with these posts.
Either one believes that VCR works, will save lives and be commercialised and therefore invest in a potential life saving device, or one panics thinking that a death means that the device does not work, and therefore sells.
Those who hold could be called investors who hold the shares in the hope that all works.
There are manipulators however who haunt these forums hoping to find a trading opportunity and therefore ramp up or down depending on whether they want to buy or sell and try and pick on one or two posters here who may have access to medical knowledge to decipher whether a product such as the ventrasist device is worthy of their investment.
There are many fledgling biotech companies in australia worthy of such investment and where would medical science be if all listened to the likes of Paul Bastow or David Walls who seem to dominate these forums to bestow their lack of knowledge on the not so mature traders here.
Either you want to believe in it or you dont.
The company is making it quite clear to us that they think this device is worthy of commercialisation and hence I will and have put my money where my mouth is and invested in ventracor and hold the shares until they become commercially viable.
In the long term, if one believes that VCR is eventually going to be a $10 or $20 company it makes little difference to myself whether I paid $1.20 or 2.50.
I belive it will be.
Using a p/e on this does not work
Charting probably does not work either.
If unsure, stay away and leave it to those who do understand.
- Forums
- ASX - By Stock
- VCR
- next trials
VCR
ventracor limited
next trials, page-6
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VCR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online